Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer’s disease: analysis of effects of baseline features on treatment response

BACKGROUND: Treatment of Alzheimer’s disease with acetylcholinesterase inhibitors can result in symptomatic benefits, but patients often show variable responses. The objective of this post hoc analysis was to investigate relationships between easily identifiable baseline characteristics/demographics...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Sabbagh, Marwan, Cummings, Jeffrey, Christensen, Daniel, Doody, Rachelle, Farlow, Martin, Liu, Liang, Mackell, Joan, Fain, Randi
Format: Artigo
Język:Inglês
Wydane: BioMed Central 2013
Hasła przedmiotowe:
Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3681558/
https://ncbi.nlm.nih.gov/pubmed/23742728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2318-13-56
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy